Literature DB >> 2387521

Tumour necrosis factor, cholestatic jaundice, and chronic liver disease.

A Jones1, P J Selby, C Viner, S Hobbs, M E Gore, T J McElwain.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2387521      PMCID: PMC1378628          DOI: 10.1136/gut.31.8.938

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  19 in total

1.  Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism.

Authors:  M L Sherman; D R Spriggs; K A Arthur; K Imamura; E Frei; D W Kufe
Journal:  J Clin Oncol       Date:  1988-02       Impact factor: 44.544

Review 2.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

3.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

4.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

5.  Antiviral effects of recombinant tumour necrosis factor in vitro.

Authors:  J Mestan; W Digel; S Mittnacht; H Hillen; D Blohm; A Möller; H Jacobsen; H Kirchner
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

6.  Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum.

Authors:  J Taverne; N Matthews; P Depledge; J H Playfair
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

7.  Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity.

Authors:  N Sato; T Goto; K Haranaka; N Satomi; H Nariuchi; Y Mano-Hirano; Y Sawasaki
Journal:  J Natl Cancer Inst       Date:  1986-06       Impact factor: 13.506

8.  Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor.

Authors:  T Shirai; H Yamaguchi; H Ito; C W Todd; R B Wallace
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

9.  Endotoxin-induced serum factor kills malarial parasites in vitro.

Authors:  J Taverne; H M Dockrell; J H Playfair
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

10.  Tumour necrosis factor in man: clinical and biological observations.

Authors:  P Selby; S Hobbs; C Viner; E Jackson; A Jones; D Newell; A H Calvert; T McElwain; K Fearon; J Humphreys
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

View more
  6 in total

1.  Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors.

Authors:  M Trauner; M Arrese; H Lee; J L Boyer; S J Karpen
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

Review 2.  Nutrition in cancer patients.

Authors:  S Mercadante
Journal:  Support Care Cancer       Date:  1996-01       Impact factor: 3.603

3.  Expression of TNF-alpha and immunohistochemical distribution of hepatic macrophage surface markers in carbon tetrachloride-induced chronic liver injury in rats.

Authors:  C Orfila; J C Lepert; L Alric; G Carrera; M Beraud; J P Vinel; B Pipy
Journal:  Histochem J       Date:  1999-10

Review 4.  The role of inflammation in cholestasis: clinical and basic aspects.

Authors:  Astrid Kosters; Saul J Karpen
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

5.  Intrahepatic cholestasis as a paraneoplastic syndrome associated with pheochromocytoma.

Authors:  C H Chung; C H Wang; C Y Tzen; C P Liu
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

6.  Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis.

Authors:  Laurent Spahr; Laura Rubbia-Brandt; Muriel Genevay; Antoine Hadengue; Emiliano Giostra
Journal:  BMC Gastroenterol       Date:  2011-10-28       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.